BG reports quarterly results April 29 against a backdrop of near-term price momentum and positioning that tilts bullish. The stock closed Friday at $124.90, up 4.7% over the past week. Short interest stands at 2.9% of the float – modest by any measure – and has edged lower, down 2.5% over the past seven days. Borrow remains cheap at 0.45% and stable. Options traders have swung more optimistic over the past month: the put/call ratio now sits at 0.28, well below its 20-day mean and more than one standard deviation into call-heavy territory.
The Street has steadily raised targets since the last print. Barclays lifted its price objective to $145 in early April, matching UBS at the top of the range. JPMorgan, Morgan Stanley, and BMO all moved their numbers higher following the March earnings beat, which sent the stock up 3.3% on the day and 6% over the subsequent week. The consensus target of $135.56 implies roughly 8.5% upside from current levels. Bulls point to expected improvement in the Milling segment and stronger second-half board crush curves as biofuel policy clarity drives demand. Bears note sharp declines in Agribusiness EBIT, weakness in Refined & Specialty Oils, and the projected year-over-year drop in merchandising results. Valuation has compressed – the stock now trades at 13.8× trailing earnings, down from over 15× a month ago, and the EV/EBITDA multiple has declined to 10.2×.
Institutional activity has been steady. Vanguard, BlackRock, and State Street all added to positions in the first quarter, while Capital Research lifted its stake by 2.5 million shares in January. Insider selling totaled roughly $8.3 million over the past 90 days, concentrated in mid-March when CEO Greg Heckman sold nearly $4.9 million of stock at $125.63 – close to the current price. The trades were programmatic and low-significance by ORTEX measures, but the timing and cluster of executives participating is worth noting. Past earnings reactions have been mixed: the February print dropped 2.5% on the day before recovering, while March saw the 3%-plus pop. On average, the stock has moved modestly higher in the week following results over the past year.
The print will test whether the company can deliver on its improved full-year outlook and whether the Milling recovery and biofuel tailwinds are large enough to offset continued pressure in Agribusiness and merchandising.
See the live data behind this article on ORTEX.
Open BG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
